Standout Papers

The National Cancer Institute: cancer drug discovery and development program. 1992 2026 2003 2014 643
  1. The National Cancer Institute: cancer drug discovery and development program. (1992)
    Michael R. Grever, Saul A. Schepartz et al. PubMed
  2. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials (2001)
    J I Johnson, Shannon Decker et al. British Journal of Cancer

Immediate Impact

3 by Nobel laureates 31 from Science/Nature 62 standout
Sub-graph 1 of 24

Citing Papers

Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
2024 StandoutNature
The neuroscience of cancer
2023 StandoutNature
2 intermediate papers

Works of Saul A. Schepartz being referenced

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
2001 Standout

Author Peers

Author Last Decade Papers Cites
Saul A. Schepartz 487 91 52 724 477 35 1.7k
Giuseppe Cassinelli 392 62 27 857 539 48 1.7k
Michael C. Bibby 383 106 63 761 285 46 1.6k
Nicolas Guilbaud 474 189 62 1167 463 68 1.9k
Jian Ding 204 59 15 722 279 38 1.4k
N R Bachur 598 94 55 981 399 43 2.1k
Kiyohiro Nishikawa 393 52 35 756 345 56 1.4k
Linjiang Tong 584 355 45 1463 671 98 2.3k
Daniel V. LaBarbera 507 97 28 709 177 53 1.9k
KUNIO ISSHIKI 205 24 41 849 397 57 1.4k
Manu Lopus 504 94 193 895 299 64 1.8k

All Works

Loading papers...

Rankless by CCL
2026